# Fimasartan/Amlodipine Combination Phase III

Study · id `cardio:ct-nct02152306` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02152306](<https://clinicaltrials.gov/study/NCT02152306>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02152306

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 143 participants.

## Technical summary

Registry record NCT02152306. Randomized; double masking; primary purpose treatment. Start 2014-04 (registry gives no type); primary completion 2015-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 143 participants (enrolled count; ClinicalTrials.gov record NCT02152306, source copy `cardio:ctgov-nct02152306-2015-07-27`, retrieved 2026-10-26)
- Start date: 2014-04 (registry gives no type) (ClinicalTrials.gov record NCT02152306, source copy `cardio:ctgov-nct02152306-2015-07-27`, retrieved 2026-10-26)
- Primary completion: 2015-03 (actual) (ClinicalTrials.gov record NCT02152306, source copy `cardio:ctgov-nct02152306-2015-07-27`, retrieved 2026-10-26)
- Completion: 2015-07 (actual) (ClinicalTrials.gov record NCT02152306, source copy `cardio:ctgov-nct02152306-2015-07-27`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02152306, source copy `cardio:ctgov-nct02152306-2015-07-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02152306-2015-07-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Fimasartan/Amlodipine Combination Phase III
- Condition: Essential Hypertension
- Intervention (Drug): Fimasartan and Amlodipine
- Intervention (Drug): Fimasartan
- Lead sponsor: Boryung Pharmaceutical Co., Ltd
- Lead sponsor class: INDUSTRY
- Collaborator: Gachon University Gil Medical Center
- Collaborator class: OTHER
- Collaborator: The Catholic University of Korea
- Collaborator class: OTHER
- Collaborator: Kangbuk Samsung Hospital
- Collaborator class: OTHER
- Collaborator: Kyungpook National University Hospital
- Collaborator class: OTHER
- Collaborator: Keimyung University Dongsan Medical Center
- Collaborator class: OTHER
- Collaborator: Korea University Guro Hospital
- Collaborator class: OTHER
- Collaborator: Korea University Anam Hospital
- Collaborator class: OTHER
- Collaborator: DongGuk University
- Collaborator class: OTHER
- Collaborator: Dong-A University Hospital
- Collaborator class: OTHER
- Collaborator: Pusan National University Hospital
- Collaborator class: OTHER
- Collaborator: Seoul National University Bundang Hospital
- Collaborator class: OTHER
- Collaborator: Seoul National University Hospital
- Collaborator class: OTHER
- Collaborator: Asan Medical Center
- Collaborator class: OTHER
- Collaborator: Pusan National University Yangsan Hospital
- Collaborator class: OTHER
- Collaborator: Wonju Severance Christian Hospital
- Collaborator class: OTHER
- Collaborator: Gangnam Severance Hospital
- Collaborator class: OTHER
- Collaborator: Severance Hospital
- Collaborator class: OTHER
- Collaborator: Ulsan University Hospital
- Collaborator class: OTHER
- Collaborator: Inje University
- Collaborator class: OTHER
- Collaborator: Inje University Haeundae Paik Hospital
- Collaborator class: OTHER
- Collaborator: Chonnam National University Hospital
- Collaborator class: OTHER
- Collaborator: Jeju National University Hospital
- Collaborator class: OTHER
- Collaborator: Chungnam National University
- Collaborator class: OTHER
- Collaborator: Hanyang University Seoul Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy (`cardio:pubmed-27502326`)

Courtesy of the U.S. National Library of Medicine.

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 23 registry organizations

## Provenance

Content hash: 725b8c2255461b92bc68c83f53fb0ebca318b650c468dbc54e69b9f0d9721339
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
